Scholar Rock Holding Corp (SRRK)
27.67
-0.75
(-2.64%)
USD |
NASDAQ |
Nov 04, 16:00
27.67
0.00 (0.00%)
After-Hours: 07:47
Scholar Rock Enterprise Value: 2.074B for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 2.074B |
| November 01, 2024 | 2.134B |
| October 31, 2024 | 2.136B |
| October 30, 2024 | 2.259B |
| October 29, 2024 | 2.335B |
| October 28, 2024 | 2.295B |
| October 25, 2024 | 2.253B |
| October 24, 2024 | 2.181B |
| October 23, 2024 | 2.096B |
| October 22, 2024 | 2.189B |
| October 21, 2024 | 2.257B |
| October 18, 2024 | 2.305B |
| October 17, 2024 | 2.201B |
| October 16, 2024 | 2.181B |
| October 15, 2024 | 2.144B |
| October 14, 2024 | 2.142B |
| October 11, 2024 | 1.981B |
| October 10, 2024 | 1.952B |
| October 09, 2024 | 2.082B |
| October 08, 2024 | 2.220B |
| October 07, 2024 | 2.603B |
| October 04, 2024 | 453.42M |
| October 03, 2024 | 425.41M |
| October 02, 2024 | 447.82M |
| October 01, 2024 | 455.82M |
| Date | Value |
|---|---|
| September 30, 2024 | 500.64M |
| September 27, 2024 | 558.26M |
| September 26, 2024 | 551.86M |
| September 25, 2024 | 548.66M |
| September 24, 2024 | 551.06M |
| September 23, 2024 | 553.46M |
| September 20, 2024 | 611.09M |
| September 19, 2024 | 540.66M |
| September 18, 2024 | 521.45M |
| September 17, 2024 | 519.05M |
| September 16, 2024 | 507.84M |
| September 13, 2024 | 545.46M |
| September 12, 2024 | 520.65M |
| September 11, 2024 | 555.06M |
| September 10, 2024 | 579.07M |
| September 09, 2024 | 539.06M |
| September 06, 2024 | 502.24M |
| September 05, 2024 | 547.06M |
| September 04, 2024 | 562.27M |
| September 03, 2024 | 587.88M |
| August 30, 2024 | 603.88M |
| August 29, 2024 | 605.48M |
| August 28, 2024 | 583.07M |
| August 27, 2024 | 584.67M |
| August 26, 2024 | 613.49M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-45.07M
Minimum
Jul 01 2022
2.603B
Maximum
Oct 07 2024
559.53M
Average
381.00M
Median
Enterprise Value Benchmarks
| Cytokinetics Inc | 5.655B |
| Regeneron Pharmaceuticals Inc | 83.27B |
| Ocugen Inc | 260.88M |
| Mirum Pharmaceuticals Inc | 1.958B |
| NeuroBo Pharmaceuticals Inc | -6.462M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -58.51M |
| Total Expenses (Quarterly) | 59.50M |
| EPS Diluted (Quarterly) | -0.60 |
| Earnings Yield | -8.02% |
| Normalized Earnings Yield | -10.99 |